Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is DD3 a new prostate-specific gene?

Orietta Gandini1, Letizia Luci, Antonio Stigliano

  • 1Department of Experimental Medicine and Pathology, Section of Pathologic Anatomy, University La Sapienza of Rome, Viale Regina Elena 324, 00161 Rome, Italy.

Anticancer Research
|April 12, 2003
PubMed
Summary

Researchers identified the DD3 gene as a potential marker for prostate cancer. Exon 4 of the DD3 gene is specifically expressed in prostate tissues, making it a promising prostate-specific molecular marker.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study.

The lancet. Diabetes & endocrinology·2026
Same author

Addison's disease in Italy: mortality and survival by etiology.

Journal of endocrinological investigation·2026
Same author

Matched Analysis of Circulating and Adipose Tissue SIRT1 Protein Level in Human Obesity.

Nutrients·2026
Same author

Efficacy and safety of relacorilant for the treatment of patients with Cushing's syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study.

The lancet. Diabetes & endocrinology·2026
Same author

Oxytocin, Weight Loss and Ketosis in Response to a Very-Low-Calorie Ketogenic Diet: An Exploratory Study.

Nutrients·2026
Same author

Effect of sitagliptin vs. placebo on bone mineralization in women with type 2 diabetes: the SLowDOWN (SitagLiptin in Diabetes for Osteoporosis in WomeN) randomized clinical trial.

BMC medicine·2025

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer diagnosis relies on identifying specific molecular markers.
  • The DD3 gene has been identified as a potential candidate for such markers.

Purpose of the Study:

  • To investigate the expression pattern of the DD3 gene across various human tissues.
  • To determine if DD3 gene expression is specific to prostate tissues.

Main Methods:

  • Reverse transcription polymerase chain reaction (RT-PCR) was employed to analyze DD3 gene expression.
  • Primers were designed to amplify different regions of the DD3 gene, including one specific to exon 4.

Main Results:

  • DD3 gene expression was detected in all tested samples when primers amplified exons 1 and 3.

Related Experiment Videos

  • However, a prostate-specific expression pattern was observed only when using primers downstream of exon 4, detecting the expected band solely in benign and malignant prostatic tissues.

    • Conclusions:

    • Exon 4 represents the prostate-specific region of the DD3 gene.
    • This finding highlights the potential of DD3 exon 4 as a highly specific molecular marker for prostate cancer detection.